SHNUF yields 10.00% · PFE yields 6.13%● Live data
📍 SHNUF pulled ahead of the other in Year 1
Combined, SHNUF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SHNUF + PFE for your $10,000?
Intouch Holdings Public Company Limited, through its subsidiaries, engages in the satellite, Internet, telecommunications, and media and advertising businesses. It operates through Local Wireless Telecommunications, Satellite and International Businesses, and Other Businesses segments. The company offers transponder rental and related services for domestic and international communications; broadband content services; satellite uplink-downlink, broadcasting television and telecommunication services; Internet data center, Internet, and telecommunication services; advertising, insurance broker, and other related services; and sale and service related to media, telephone network, mobile content, and engineering development services on communication technology and electronics. It also sells user terminals of IPSTAR and direct television equipment; and distributes internet equipment. In addition, the company offers local mobile telecommunication services; provides computer program and related services, as well as information technology and home shopping services; and trades in and rents telecommunications equipment and accessories. It has operations in Thailand, Australia, India, Japan, Myanmar, Malaysia, and internationally. The company was formerly known as Shin Corporation Public Company Limited and changed its name to Intouch Holdings Public Company Limited in March 2014. Intouch Holdings Public Company Limited was founded in 1983 and is based in Bangkok, Thailand. As of December 31, 2021, Intouch Holdings Public Company Limited operates as a subsidiary of Gulf Energy Development Public Company Limited.
Full SHNUF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.